Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Submitted by
admin
on November 7, 2017 - 10:55am
Source:
Fierce Pharma
News Tags:
Roche
Alecensa
Pfizer
Novartis
lung cancer
Zykadia
Xalkori
Headline:
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Do Not Allow Advertisers to Use My Personal information
